Propofol
Provive is an injection solution that contains the active substance propofol. Propofol belongs to a group of medicines called anesthetics. These medicines are used to induce loss of consciousness (deep sleep) for surgical procedures or other interventions. It can also be used to achieve sedation (a state in which the patient is sleepy but not completely asleep). Provive is used for:
If the patient experiences any of the following conditions, there is a risk of very rare side effects. These conditions include:
Tell your doctor or pharmacist about all medicines the patient is taking or has recently taken, including those obtained without a prescription. If the patient is taking any of the following medicines, side effects may occur when used in combination with propofol. This includes:
If the patient is pregnant or breastfeeding, thinks she may be pregnant, or plans to have a baby, she should consult her doctor or pharmacist before using this medicine. Provive should not be given to pregnant women unless absolutely necessary. Due to the safety of the baby during the use of Provive, breastfeeding should be stopped.
The ability to drive and use machines may be impaired for some time after the procedure due to the use of this medicine. If the patient returns home on the day of the procedure, they should not drive or operate machinery. If necessary, the patient should ask their doctor when they can return to work.
Provive contains soybean oil. Do not use if you are allergic to peanuts or soy.
In people with an allergy to this ingredient, its presence may be a problem. This medicine contains less than 1 mmol of sodium (23 mg) per dose, which means it is essentially "sodium-free".
If you have any further questions about using this medicine, ask your doctor, pharmacist, or nurse.
Like all medicines, Provive can cause side effects, although not everybody gets them. The following side effects have been reported:
Very common(may affect more than 1 in 10 people):
Uncommon(may affect up to 1 in 100 people):
Rare(may affect up to 1 in 1,000 people):
Very rare(may affect up to 1 in 10,000 people):
Frequency not known(cannot be estimated from the available data):
If you experience any side effects, including those not listed in this package leaflet, tell your doctor, pharmacist, or nurse. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products: Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: 22 49-21-301, fax: 22 49-21-309, website: https://smz.ezdrowie.gov.pl. Side effects can also be reported to the marketing authorization holder. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children. Provive is stored in a hospital. The hospital staff is responsible for the proper storage, use, and disposal of Provive. Do not use this medicine after the expiry date stated on the packaging after (EXP). The expiry date refers to the last day of the month stated. Do not store above 25°C. Store in the original packaging to protect from light. Do not store in a refrigerator or freeze. After first opening, use immediately. Shake the vial before use. Do not use the emulsion if two layers are visible after shaking. Only use medicine with a uniform consistency and undamaged packaging. For single use only. Discard any unused emulsion. Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
The active substance is propofol. Each 1 ml of emulsion for injection contains 10 mg of propofol. One vial of 10 ml of the medicine contains 100 mg of propofol. One vial of 20 ml of the medicine contains 200 mg of propofol. One vial of 50 ml of the medicine contains 500 mg of propofol. One vial of 100 ml of the medicine contains 1000 mg of propofol. The other ingredients are purified soybean oil, glycerol, egg yolk lecithin, sodium oleate, sodium hydroxide (for pH adjustment), and water for injections.
Provive 10 mg/ml is a white emulsion for injection or infusion. The medicine is provided in a colorless glass type II vial, closed with a gray rubber stopper and a plastic cap. The pack sizes are: 10 ml colorless glass type II vial with a gray rubber stopper, pack contains 1 vial. 20 ml colorless glass type II vial with a gray rubber stopper, pack contains 1, 5, or 10 vials. 50 ml colorless glass type II vial with a gray rubber stopper, pack contains 1 vial. 100 ml colorless glass type II vial with a gray rubber stopper, pack contains 1 vial. Not all pack sizes may be marketed.
Baxter Holding B.V. Kobaltweg 49, 3542 CE Utrecht, Netherlands
Tramco Sp. z.o.o Wolskie, ul. Wolska 14, 05-860 Płochocin, Poland Bieffe Medital S.p.A. Via Nuova Provinciale, 23034 Grosotto (SO), Italy UAB Norameda, Meistru 8a, 02189, Vilnius, Lithuania Date of last revision of the package leaflet:31 July 2024
Provive can only be administered in hospitals or in medical institutions equipped with adequate equipment by doctors specializing in anesthesiology or intensive care. The patient's cardiovascular and respiratory functions should be continuously monitored, and equipment for maintaining airway patency, artificial ventilation, oxygen administration, and other resuscitation equipment should be available at all times. Provive 10 mg/ml should not be administered by the person performing the diagnostic or surgical procedure. The infusion set should include a burette, drop counter, or volumetric infusion pump to prevent the risk of uncontrolled administration of large volumes of diluted Provive 10 mg/ml. The vial should be shaken before use. Do not use the emulsion if two layers are visible after shaking. Only use medicine with a uniform consistency and undamaged packaging. For single use only. Discard any unused medicine. Before use, clean the rubber membrane with alcohol in a spray or swab. After use, discard opened vials. Provive 10 mg/ml is a fat emulsion that does not contain preservatives and may support the growth of microorganisms. The emulsion should be drawn up into a sterile syringe or infusion set immediately after piercing the vial cap. Administration of the medicine should be started immediately. During the entire infusion period, the sterility of Provive and the infusion set should be maintained. Any infusion fluids added to the infusion system through which Provive is administered should be given close to the site of venflon insertion. Do not administer Provive through infusion systems equipped with microbiological filters. Provive 10 mg/ml and any infusion sets containing Provive 10 mg/ml are intended for single use in one patient. Any unused Provive 10 mg/ml should be discarded.
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.